Raghu Saripalli

Raghu Saripalli is the CFO of Endeavor Biomedicines, a biotech startup in San Diego. Prior to that, he was co-founder and CFO of Impact Biomedicines, which was acquired by Celgene Corporation.

Since moving to San Diego in 2003, Mr. Saripalli has been working with early-stage and small companies mostly focused on biotech. Prior to that, he was an investment banker in New York. Over a period of ten years, he worked at Barclays Capital, Deutsche Bank, and Wasserstein Perella in mergers and acquisitions with a focus on gaming and defense.

Mr. Saripalli has a B.S. in Mechanical Engineering from the National Institute of Technology (India), dual Master of Science in Mechanical Engineering and Computer Science, and an MBA (with distinction) from The Wharton School of the University of Pennsylvania.